Small Molecule API Market Research Report Information By Types (Synthetic/Chemical API and Biological API), By Application (Cardiovascular, Oncology, Diabetes, and Immunological Disorders), By Manufacturing Method (In-House and Contract), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Technique

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Analysis

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. COVID-19 Impact Analysis

5.3.1. Market Impact Analysis

5.3.2. Regional Impact

5.3.3. Opportunity and Threat Analysis

6. GLOBAL SMALL MOLECULE API , BY TYPE

6.1. Overview

6.2. Synthetic/Chemical API

6.3. Biological API

7. GLOBAL SMALL MOLECULE API , BY MANUFACTURING METHOD

7.1. Overview

7.2. In-House

7.3. Contract

8. GLOBAL SMALL MOLECULE API , BY APPLICATION

8.1. Overview

8.2. Cardiovascular

8.3. Oncology

8.4. Diabetes

8.5. Immunological Disorders

9. GLOBAL SMALL MOLECULE API , BY REGION

9.1. Overview

9.1. North America

9.1.1. US

9.1.2. Canada

9.2. Europe

9.2.1. Germany

9.2.2. France

9.2.3. UK

9.2.4. Italy

9.2.5. Spain

9.2.6. Rest of Europe

9.3. Asia-Pacific

9.3.1. China

9.3.2. India

9.3.3. Japan

9.3.4. South Korea

9.3.5. Australia

9.3.6. Rest of Asia-Pacific

9.4. Rest of the World

9.4.1. Middle East

9.4.2. Africa

9.4.3. Latin America

10. COMPANY LANDSCAPE

10.1. Overview

10.2. Competitive Analysis

10.3. Market Share Analysis

10.4. Major Growth Strategy in the Global Small Molecule API

10.5. Competitive Benchmarking

10.6. Leading Players in Terms of Number of Developments in the Global Small Molecule API

10.7. Key developments and Growth Strategies

10.7.1. New Product Launch

10.7.2. Merger & Acquisitions

10.7.3. Joint Ventures

10.8. Major Players Financial Matrix

10.8.1. Sales & Operating Income, 2022

10.8.2. Major Players R&D Expenditure. 2022

11. COMPANY PROFILES

11.1. Teva Pharmaceuticals

11.1.1. Company Overview

11.1.2. Financial Overview

11.1.3. Product Offered

11.1.4. Key Developments

11.1.5. SWOT Analysis

11.1.6. Key Strategies

11.2. Allergan

11.2.1. Company Overview

11.2.2. Financial Overview

11.2.3. Product Offered

11.2.4. Key Developments

11.2.5. SWOT Analysis

11.2.6. Key Strategies

11.3. BASF SE

11.3.1. Company Overview

11.3.2. Financial Overview

11.3.3. Product Offered

11.3.4. Key Developments

11.3.5. SWOT Analysis

11.3.6. Key Strategies

11.4. Siegfried Holding AG.

11.4.1. Company Overview

11.4.2. Financial Overview

11.4.3. Product Offered

11.4.4. Key Developments

11.4.5. SWOT Analysis

11.4.6. Key Strategies

11.5. Sun Pharmaceuticals

11.5.1. Company Overview

11.5.2. Financial Overview

11.5.3. Product Offered

11.5.4. Key Developments

11.5.5. SWOT Analysis

11.5.6. Key Strategies

11.6. Sanofi S.A

11.6.1. Company Overview

11.6.2. Financial Overview

11.6.3. Product Offered

11.6.4. Key Developments

11.6.5. SWOT Analysis

11.6.6. Key Strategies

11.7. Albany Molecular Research Inc

11.7.1. Company Overview

11.7.2. Financial Overview

11.7.3. Product Offered

11.7.4. Key Developments

11.7.5. SWOT Analysis

11.7.6. Key Strategies

11.8. Novartis AG

11.8.1. Company Overview

11.8.2. Financial Overview

11.8.3. Product Offered

11.8.4. Key Developments

11.8.5. SWOT Analysis

11.8.6. Key Strategies

11.9. Albemarle Corporation

11.9.1. Company Overview

11.9.2. Financial Overview

11.9.3. Product Offered

11.9.4. Key Developments

11.9.5. SWOT Analysis

11.9.6. Key Strategies

11.10. Merck Sharp & Dohme Corp.

11.10.1. Company Overview

11.10.2. Financial Overview

11.10.3. Product Offered

11.10.4. Key Developments

11.10.5. SWOT Analysis

11.10.6. Key Strategies

12. APPENDIX

12.1. References

12.2. Related Reports

LIST OF TABLES

TABLE 1 GLOBAL SMALL MOLECULE API MARKET, SYNOPSIS, 2019–2032

TABLE 2 GLOBAL SMALL MOLECULE API MARKET, ESTIMATES & FORECAST, 2019–2032 (USD MILLION)

TABLE 3 GLOBAL SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 4 GLOBAL SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL SMALL MOLECULE API MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 NORTH AMERICA: SMALL MOLECULE API MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 8 NORTH AMERICA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 9 NORTH AMERICA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 10 NORTH AMERICA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 11 US: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 12 US: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 13 US: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 14 CANADA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 15 CANADA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 16 CANADA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 17 EUROPE: SMALL MOLECULE API MARKET, BY COUNTRY 2019–2032 (USD MILLION)

TABLE 18 EUROPE: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 19 EUROPE: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 20 EUROPE: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 21 GERMANY: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 22 GERMANY: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 23 GERMANY: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 24 FRANCE: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 25 FRANCE: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 26 FRANCE: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 27 ITALY: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 28 ITALY: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 29 ITALY: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 30 SPAIN: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 31 SPAIN: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 32 SPAIN: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 33 UK: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 34 UK: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 35 UK: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 36 REST OF EUROPE: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 37 REST OF EUROPE: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 38 REST OF EUROPE: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 39 ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 40 ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 41 ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 42 ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 43 JAPAN: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 44 JAPAN: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 45 JAPAN: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 46 CHINA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 47 CHINA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 48 CHINA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 49 INDIA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 50 INDIA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 51 INDIA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 52 AUSTRALIA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 53 AUSTRALIA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 54 AUSTRALIA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 55 SOUTH KOREA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 56 SOUTH KOREA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 57 SOUTH KOREA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 58 REST OF ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 59 REST OF ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 60 REST OF ASIA-PACIFIC: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 61 MILLION)

TABLE 62 REST OF THE WORLD: SMALL MOLECULE API MARKET, BY COUNTRY 2019–2032 (USD MILLION)

TABLE 63 REST OF THE WORLD: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 64 REST OF THE WORLD: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 65 REST OF THE WORLD: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 66 MIDDLE EAST: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 67 MIDDLE EAST: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 68 MIDDLE EAST: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 69 AFRICA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 70 AFRICA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 71 AFRICA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

TABLE 72 LATIN AMERICA: SMALL MOLECULE API MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 73 LATIN AMERICA: SMALL MOLECULE API MARKET, BY MANUFACTURING METHOD, 2019–2032 (USD MILLION)

TABLE 74 LATIN AMERICA: SMALL MOLECULE API MARKET, BY APPLICATION, 2019–2032 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL SMALL MOLECULE API MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL SMALL MOLECULE API MARKET

FIGURE 4 GLOBAL SMALL MOLECULE API MARKET, SHARE (%), BY TYPE, 2022

FIGURE 5 GLOBAL SMALL MOLECULE API MARKET, SHARE (%), BY MANUFACTURING METHOD, 2022

FIGURE 6 GLOBAL SMALL MOLECULE API MARKET, SHARE (%), BY APPLICATION, 2022

FIGURE 7 GLOBAL SMALL MOLECULE API MARKET, SHARE (%), BY REGION, 2022

FIGURE 8 NORTH AMERICA: SMALL MOLECULE API MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 9 EUROPE: SMALL MOLECULE API MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 10 ASIA-PACIFIC: SMALL MOLECULE API MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 11 REST OF THE WORLD: SMALL MOLECULE API MARKET, SHARE (%), BY COUNTRY, 2022

FIGURE 12 GLOBAL SMALL MOLECULE API MARKET: COMPANY SHARE ANALYSIS (%), 2022

FIGURE 13 TEVA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 14 TEVA PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 15 ALLERGAN: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 16 ALLERGAN: SWOT ANALYSIS

FIGURE 17 BASF SE: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 18 BASF SE: SWOT ANALYSIS

FIGURE 19 SIEGFRIED HOLDING AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 20 SIEGFRIED HOLDING AG: SWOT ANALYSIS

FIGURE 21 SUN PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 22 SUN PHARMACEUTICALS: SWOT ANALYSIS

FIGURE 23 SANOFI S.A: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 24 SANOFI S.A: SWOT ANALYSIS

FIGURE 25 ALBANY MOLECULAR RESEARCH INC: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 26 ALBANY MOLECULAR RESEARCH: SWOT ANALYSIS

FIGURE 27 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 28 NOVARTIS AG: SWOT ANALYSIS

FIGURE 29 ALBEMARLE CORPORATION: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 30 ALBEMARLE CORPORATION: SWOT ANALYSIS

FIGURE 31 MERCK SHARP & DOHME COR: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 32 MERCK SHARP & DOHME COR: SWOT ANALYSIS